Introduction
CD127, the IL7Ra chain, forms a heterodimer with the IL2Rg chain to bind IL7, and a heterodimer with the TSLPR (thymic stromal lymphopoietin receptor) to bind TSLP. Both cytokines affect the constitution of the T cell compartment. IL7 promotes T cell proliferation, survival, and differentiation; and its expression is used to select between T cell types in the thymus and periphery. 1, 2 TSLP also modulates T cell types by facilitating the differentiation of regulatory T cells (Tregs) in Hassall's corpuscles of the thymus, 3 and by promoting Th2 differentiation in the periphery. 4 IL7 has been investigated as a therapy to aid in reconstitution of the T cell compartment following lymphopenia caused by administration of cancer chemotherapeutic agents, diseases or transplantation. 5 T cell repopulation following antiretroviral therapy of HIV is highly variable between patients, and IL7 has been suggested to enhance that repopulation. 6, 7 The clinical use of IL7 has shown promise in accelerating recovery from lymphopenia. 8 In multiple sclerosis (MS) patients, restoration of normal lymphocyte populations following anti-CD52 (Campath) treatment is unusually slow, and the T cell subsets and IL7 levels are abnormal. 9 T cell repertoires are also aberrant after stem cell transplantation in MS. 10 A donor CD127 haplotype has been reported recently to be associated with reduced mortality following bone marrow transplantation, possibly because it favors more rapid proliferation of T cells, or it favors tolerance mechanisms. 11 The factors affecting restoration of the lymphocyte compartment in many clinical settings need to be determined, including the effect of the common CD127 haplotypes.
Earlier, we found that CD127 was underexpressed in the peripheral blood cells of patients with the primary progressive form of multiple sclerosis (PPMS). The haplotypes containing the À504 T allele were associated with lower expression of CD127 and associated with disease in two independent cohorts of Australian PPMS patients. 12 The haplotypic association of CD127 has now been identified in large cohorts of Scandinavian, American and UK MS patients [13] [14] [15] confirming it as the second gene to be unequivocally associated with MS, after HLA DRB1501. These haplotypes include promoter and codon-changing polymorphisms 16 ( Figure 1 ). The functionally significant single nucleotide polymorphism (SNP) could potentially affect transcription or signal transduction, or both, probably in a context-dependent fashion.
MS is the most common cause of chronic neurological disease in young adults, and is partially heritable. 17, 18 The genes responsible for this heritability have been sought by linkage and association studies, and through candidate gene analysis. 19 The MHC Class II DRB1501 allele confers a 3-4-fold relative risk in most populations, strongly supporting a role for CD4 T cells in MS pathogenesis. Further support comes from the success of drugs which reduce or modulate T cell activation and movement, such as anti-VLA4 antibody, FTY720, interferon beta and glatiramer acetate. 20 We hypothesized that the CD127 genotypic association we detected in PPMS was due to its effect on mRNA and protein expression. Differences in transcription and cell surface protein levels due to haplotype in healthy controls and MS were sought by measuring in vivo expression in whole blood. These data suggest the haplotypes mediate significant functional differences in both health and disease.
Results
CD127 mRNA expression in whole blood and PBMC Because mRNA is labile, and can be captured with less degradation from whole blood than from cell subsets, 12 we initially studied expression in whole blood. We found that CD127 mRNA expression was significantly reduced in whole blood samples from PPMS patients (Po0.001, Figure 2a ). The reduction was independent of age, sex and genotype (data not shown). This CD127 measurement is based on comparison to the housekeeping gene, GAPDH, typically used in studies on circulating cells, 21 and presumed to be the same between compared cohorts.
As CD127 expression is very low in neutrophils, 22 and neutrophils account for the majority of mRNA in whole blood, we tested peripheral blood mononucleocytes (PBMC) RNA (that is, neutrophil depleted component), and found that CD127 mRNA expression was still much lower in PPMS (Pp0.003, Figure 2b ). The majority of mRNA from PBMCs is from T cells (typically 80%). 23 B cells and NK cells are typically less than 10%, and produce little CD127 mRNA. 22 Macrophages and monocytes, produce less CD127 mRNA than T cells, and are about 10% of the PBMC fraction. The recapitulation of the measurement of reduced CD127 mRNA in PPMS whole blood in the PBMC fraction comparison indicates that the lymphocyte and monocyte component of whole blood is the likely major source of the observed difference in CD127 mRNA levels. We also tested whether the percentage of neutrophils was increased in PPMS whole blood. We found it was 14% higher in PPMS (Pp0.02, Figure 2c ). This is likely to account for some of the observed reduction in PPMS CD127 mRNA from whole blood. CD127 has two common mRNA isoforms, one encoding full-length protein, which is membrane-bound, and the other with exon 6 spliced out to encode soluble receptor. We measured the proportion of each form in whole blood mRNA, and found PPMS and RRMS patients expressed significantly more of the soluble form than healthy controls (Pp0.002, Figure 2d ). full-length (membrane-bound) and soluble mRNA isoforms from whole blood (from 31 CON, 26 PPMS and 16 RRMS subjects). In each case the probability refers to the comparison between the MS cohort and healthy controls, using the Wilcoxon test. Figure 3a) . The full length/soluble isoform ratio was also not affected by haplotype 4 (Table 1) , but was significantly correlated with the other haplotypes in PPMS, and if MS and control data are combined (Pp0.001). The difference between haplotypes was most marked in PPMS, but the same trend could be seen in controls and RRMS ( Table 1 ). The haplotype that produces more of the soluble isoform, haplotype 1, is more common in our PPMS cohort than the healthy controls (Table 2) . Although this may have contributed to the observation of a higher proportion of the soluble isoform in PPMS whole blood (Figure 2d ), from Table 1 it can be seen that for haplotype 1 carriers and noncarriers the difference in the ratio of the isoforms is much greater for PPMS than healthy controls. In healthy controls haplotype 1 homozygotes produce significantly more of the soluble isoform than noncarriers of this haplotype, haplotype 2 homozygotes less, and there is no difference for haplotype 4 (Figure 3b ). The mRNA from heterozygotes for each haplotype is tagged by the exon 2 (haplotype 1) or exon 8 (haplotype 4) SNPs (Figure 1 (Figure 3c ). In PPMS, the protective haplotype 4 had a small but significant higher expression. Intriguingly, for RRMS subjects, there was significantly lower expression from haplotype 1.
CD127 cell surface expression was not different in T cells in disease or between haplotypes
The majority of CD127 mRNA in whole blood is produced by CD3 T cells. 21 To test if the mRNA levels and isoform differences in mRNA were also detectable at the protein level we measured membrane-bound CD127 in whole blood CD3 T cells in subjects of known genotype with flow cytometry. T cells had similar membrane-bound CD127 (mbCD127) levels in healthy controls and PPMS (Figure 4a ). The mbCD127 was not different between the different haplotypes for healthy controls or PPMS (Figures 4b and c) . Ratio of full length (membrane-bound) to soluble CD127 mRNA in whole blood for homozygotes of haplotypes compared to noncarriers (data derived from 10 (2 alleles) and 16 (0 alleles) for haplotype 1; 2 and 24 for haplotype 2, and 3 and 21 for haplotype 4, respectively); no homozygotes for the rarer haplotype 3 were present in our study (c) relative expression of exon 2 SNP tagging haplotype 1 (data from 14 CON, 12 PPMS, 13 RRMS subjects), exon 8 SNP tagging haplotype 4 (data from 14 CON, 15 PPMS, 10 RRMS subjects) in heterozygotes. A ratio of 1 indicates equal message from both haplotypes. mRNA was derived from whole blood as described in Materials and methods. Probability of ratio being different from 1 was calculated using the Sign test. 67 (50) 32 (24) 20 (15) 48 (40) Number of samples in parentheses.
Functional significance of CD127 haplotypes FC McKay et al

Discussion
Using a much larger sample than in an earlier report, 12 we have replicated that study and confirmed that CD127 mRNA is underexpressed in PPMS whole blood compared to healthy controls ( Figure 2 ). We have extended this to show that the reduction is also seen in PBMCs, thereby excluding the elevated neutrophil % in MS patients (seen by others 24 and confirmed here) as the sole cause of the findings in whole blood.
Elevated neutrophils may contribute to MS pathogenesis by increasing inflammation. Carriers of the pathogenic MEFV gene variants which can cause familial Mediterranean fever, have a 10-fold higher rate of MS disease progression. 25 MEFV homozygotes have excess neutrophil activity, which is controlled by colchicine. 26 Colchicine, therefore, may be a therapeutic option in MS. Th17 cells can promote neutrophil expansion and autoimmune diseases. 27 It is an intriguing possibility that Th17 proportions are higher in PPMS due to the CD127 genotype. There is increasing evidence that the innate immune system contributes to MS pathogenesis. Vaknin-Dembinsky et al. 28 have reported higher levels of the Th17 survival cytokine, IL23, in dendritic cells in MS. Huang et al. 29 have reported that there are higher levels of dendritic cells secreting pro-inflammatory cytokines in RRMS, and recently, Karni et al. 30 identified myeloid dendritic cells as drivers of the inflammatory response in RRMS and especially secondary progressive MS.
The CD127 haplotype 1 produces significantly more soluble CD127, and haplotype 2 less soluble CD127, particularly in PPMS (Table 1, Figure 3b ). Soluble CD127 could reduce IL7 or TSLP signaling, favoring less T cell proliferation and survival, particularly in T cell subsets with limiting expression of CD127. Characterization of T cell subsets, especially in terms of Th1, Th2, Th17, naïve vs effector/memory, and T cell clonality should be useful in MS pathogenicity studies, especially if associated with the MS-associated CD127 haplotype. It is particularly interesting that CD127 expression has been reported to be threefold lower in effector/memory (CD45RO þ ) than naïve T cells (CD45RA þ ), 31 and greatly reduced in Th1 cells compared to resting memory cells. 22 As both CD45RO þ and Th1 cells are large sources of CD127 mRNA in PBMCs, a significant imbalance, with an excess of either or both, might be expected to contribute to the measured reduction in CD127 mRNA in PPMS detected in this study.
The lack of correlation between mRNA and mbCD127 in whole blood CD3 T cells is not surprising (Figure 4) . The full-length mRNA isoform greatly exceeds the soluble isoform in blood cells, so that the number of samples needed to detect a difference in mbCD127 is probably larger than we have available. Also, transcription and protein expression may be out of phase due to dynamics of cell differentiation and migration, for example, cells producing more mRNA may be exiting from the blood before mbCD127 has increased.
Because the CD127 haplotypes have been associated with susceptibility to MS and with the rate of survival following bone marrow transplantation, it is likely they have functional significance. As this function is likely to result in differences in immune cell constitution or reconstitution, these haplotypes may be important in many immunological diseases. The haplotypes have 5 0 UTR, intronic, codon changing and 3 0 UTR SNPs, any of which could be affecting IL7-or TSLP-mediated regulation of T cells, and may even be of variable importance in different T cell diseases.
We have demonstrated that the CD127 haplotype affects gene transcription, which in turn should affect the constitution of the T cell compartment, since differential survival and development of T cell subsets according to their response to IL7 or TSLP would occur. The elevated numbers of neutrophils observed may also be pathogenically significant, and may point to another T cell subset, the pro-inflammatory pro-neutrophilic Th17 cells, as being dysregulated in PPMS. Overall, these data indicate the CD127 haplotypes are functionally significant in health and disease. Further characterization of the functional differences in the CD127 haplotypes should enhance the understanding of their role in disease pathogenesis, and of the intricate factors controlling T cell survival, differentiation and proliferation.
Materials and methods
Patients
Peripheral blood was collected from 34 subjects with primary progressive MS, 20 subjects with relapsing remitting MS, and 45 healthy controls. All subjects were diagnosed with definite MS by Poser criteria. 32 The McDonald criteria 33 for the diagnosis of PPMS, were applied retrospectively. All subjects had other relevant conditions excluded. All PPMS subjects had a clinical course which was progressive from onset with observed progressive deterioration over a period of 41 year and with prominent paraparesis and typical MRI abnormalities. CSF results were not available in all cases. The three 
Genotyping
The À1085 (rs7718919), À504 (rs11567685) and À449 SNPs (rs11567686) were genotyped by using restriction enzymes, as described previously. 12 À449 G ( þ strand) tags haplotype 1, À504 C ( þ ) tags haplotype 2, À1085 T ( þ ) tags haplotype 3 and À1085 G, À504 T, À449 A (all þ strand) tag haplotype 2 ( Figure 1 ).
Flow cytometry
Buffy coats from PPMS subjects (n ¼ 16) and healthy controls (n ¼ 32) were isolated from whole blood collected in EDTA and flow cytometric analysis was performed using a FACScan (Becton Dickinson) with CellQuest software. Fluorochrome-conjugated antibodies to the antigens were obtained from BD Biosciences (CD3-PerCP) and R&D Systems (CD127-PE).
Statistics
All statistical comparisons are by the nonparametric Wilcoxon Rank test unless otherwise stated.
